SPALLUTO, Giampiero
 Distribuzione geografica
Continente #
NA - Nord America 3.401
AS - Asia 2.002
EU - Europa 947
SA - Sud America 277
AF - Africa 30
OC - Oceania 3
Totale 6.660
Nazione #
US - Stati Uniti d'America 3.325
SG - Singapore 669
CN - Cina 589
BR - Brasile 203
VN - Vietnam 199
UA - Ucraina 187
DE - Germania 185
HK - Hong Kong 164
TR - Turchia 158
GB - Regno Unito 137
SE - Svezia 76
FI - Finlandia 73
IT - Italia 71
FR - Francia 66
IN - India 57
JP - Giappone 47
RU - Federazione Russa 40
BD - Bangladesh 36
CA - Canada 35
MX - Messico 32
AR - Argentina 29
PL - Polonia 27
ES - Italia 20
ZA - Sudafrica 18
AT - Austria 15
IQ - Iraq 15
NL - Olanda 14
EC - Ecuador 11
LT - Lituania 8
SA - Arabia Saudita 8
BE - Belgio 7
CO - Colombia 7
VE - Venezuela 7
ID - Indonesia 6
JO - Giordania 6
MA - Marocco 6
PK - Pakistan 6
BO - Bolivia 5
CZ - Repubblica Ceca 5
PE - Perù 5
AE - Emirati Arabi Uniti 4
IE - Irlanda 4
PY - Paraguay 4
TW - Taiwan 4
UZ - Uzbekistan 4
AZ - Azerbaigian 3
IR - Iran 3
MY - Malesia 3
PS - Palestinian Territory 3
AL - Albania 2
AU - Australia 2
CL - Cile 2
CR - Costa Rica 2
CY - Cipro 2
GY - Guiana 2
KZ - Kazakistan 2
MN - Mongolia 2
NP - Nepal 2
PH - Filippine 2
RS - Serbia 2
SV - El Salvador 2
TN - Tunisia 2
BG - Bulgaria 1
BY - Bielorussia 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
GT - Guatemala 1
HR - Croazia 1
IL - Israele 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
KR - Corea 1
KW - Kuwait 1
LB - Libano 1
LV - Lettonia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
SI - Slovenia 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TZ - Tanzania 1
UY - Uruguay 1
Totale 6.660
Città #
Singapore 434
Ashburn 307
Woodbridge 272
Chandler 251
Houston 228
San Jose 228
Fairfield 204
Jacksonville 198
Beijing 191
Ann Arbor 164
Hong Kong 164
Santa Clara 142
Nanjing 87
Wilmington 85
Dallas 76
Izmir 76
Ho Chi Minh City 67
Seattle 66
Los Angeles 61
Cambridge 53
Munich 49
New York 49
Hanoi 47
Princeton 46
Tokyo 37
Boardman 35
Dearborn 35
Lauterbourg 27
Shanghai 26
São Paulo 23
Buffalo 22
London 22
Orem 22
Shenyang 22
Turku 21
Nanchang 19
Warsaw 19
Milan 18
Hefei 17
Mexico City 17
San Diego 17
Brooklyn 16
Frankfurt am Main 16
Tianjin 16
Addison 14
Chennai 14
Falkenstein 14
Helsinki 14
San Mateo 14
Vienna 14
Changsha 13
San Francisco 12
Jiaxing 11
Da Nang 10
Hebei 10
Toronto 10
Atlanta 9
Chicago 9
Jinan 9
Johannesburg 9
Moscow 9
Phoenix 9
Rio de Janeiro 9
Zhengzhou 9
Bremen 8
Council Bluffs 8
Falls Church 8
Kunming 8
Mumbai 8
Norwalk 8
Ottawa 8
Philadelphia 8
Poplar 8
Amsterdam 7
Boston 7
Manchester 7
Ningbo 7
Taizhou 7
Amman 6
Brussels 6
Haiphong 6
Montreal 6
Charlotte 5
Denver 5
Ferrara 5
Louisville 5
Rome 5
Verona 5
Ankara 4
Baghdad 4
Biên Hòa 4
Bắc Ninh 4
City of London 4
Delhi 4
Dublin 4
Hải Dương 4
Istanbul 4
Olomouc 4
Pasadena 4
Porto Alegre 4
Totale 4.423
Nome #
4-Isopropyl-2-oxazolin-5-one anion as a new convenient formyl anion equivalent for conjugate addition and aldol reactions 326
A formal total synthesis (±)-forskolin through [3+2] nitrile oxide cycloaddition chemistry 270
4-Isopropyl-2-oxazolin-5-one anion as masked umpoled synthon for both formyl and hydroxycarbonyl anions: generation, reactivity and synthetic applications 258
[H-3]MRE 3008F20: A novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors 245
Changes in cortical ACh and GABA outflow during morphine withdrawal involve alpha-1 and alpha-2 receptors 241
Enantioselective synthesis of (-)-meroquinene through tandem Michael reaction methodology 238
5‐Hydroxytryptamine‐mediated effects of nicotine on endogenous GABA efflux from guinea‐pig cortical slices 236
Synthesis, in vitro antiproliferative activity, and DNA-binding properties of hybrid molecules containing pyrrolo[2,1-c][1,4] benzodiazepine and minor-groove-binding oligopyrrole carriers 220
Mastering β-Keto Esters 217
Alpha-2 adrenoreceptor-mediated decrease in gamma-aminobutyric acid outflow in cortical slices and synaptosomes during morphine tolerance 214
Effect of acute and subchronic nicotine treatment on cortical efflux of [3H]‐d‐aspartate and endogenous GABA in freely moving guinea‐pigs 213
7-substituted-5-amino-2-(furyl)-pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonists: importance of modifications at the side chain on the activity and solubility. 209
A new synthetic approach to indazole synthesis 209
Alpha-1 adrenoreceptor-mediated increase in ACh release in brain slices during morphine tolerance 209
[3H]-MRE 3008-F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A3 adenosine receptors. 202
7-sobstituted-5-amino-2-(furyl)-pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonist: importance of modifications at the side chain on the activity and solubility. 192
[3H]MRE3008-F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A3 adenosine receptors. 191
New potent and selective human adenosine A3 receptor antagonists 180
Generation and cycloaddition reactions of 3-substituted-2-nitro-1,3- dienes 179
Pharmacological and biochemical characterization of A3 adenosine receptors in Jurkat T cells. 177
Resolution of a CPzI precursor, synthesis and biological evaluation of (+) and (-)-N-Boc-CPzI: A further validation of the relationship between chemical solvolytic stability and cytotoxicity 177
Fluorosulfonyl- and bis-(beta-chloroethyl)amino-phenylamino functionalized pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives: Irreversible antagonists at the human A(3) adenosine receptor and molecular modeling studies 144
Pharmacological and biochemical characterization of A3 adenosine receptor in Jurkat T cells. 134
Pyrazolo [4,3-E]1,2,4-triazolo[1,5-c]pyrimidine derivates a new class of potent and selective human A3 adenosine receptor antagonists. 133
Substituted 6-amino-thiouracils as new P2Y(12) receptor antagonists 126
Synthesis and molecular investigation of new pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivates as human A3 adenosine receptor antagonists. 125
Synthesis and molecular investigation of new pyrazolo[4,3-e]1,2,4,-triazolo[1,5-c]pyrimidine derivates as human A3 adenosine receptor antagonists. 119
Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]-pyrimidine derivatives as highly potent and selective human A(3) adenosine receptor antagonists 117
Synthesis and pharmacological characterization of [3H]-MRE3008F20: the first radioligand antagonist for the human A3 adenosine receptors. 115
Synthesis, binding and thermodynamic studies of new highly selective A2A adenosine receptor antagonists 115
Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives: A new pharmacological tool for the characterization of the human A(3) adenosine receptor 114
Synthesis and preliminary biological evaluation of [3H]-MRE 3008F20: the first high affinity radioligand antagonist for the human A3 adenosine receptors 113
Pyrazolo[4,3-e]1,2,4-triazolo[1,5]pyrimidine derivates as irreversible antagonists at the human A3 adenosine receptor 112
Synthesis, biological properties and molecular modelling investigation of the first potent, selective and water soluble human A3 adenosine receptor antagonist. 111
Pyrazolo-triazolo-pyrimidine as human A3 adenosine receptor antagonists: influence of the substitutent at N8 pyrazole nucleus. 106
Pyrazolo-triazolo-pyrimidine derivates as adenosine receptor ligands: a search for A2B adenosine receptor antagonists. 105
Pyrazolo [4,3-E]1,2,4-trazolo[1,5-c]pyrimidine derivatives a new class of potent and selective human A3 adenosine receptor antagonists 100
Second generation of A2A adenosine receptor antagonist: synthesis and biological evaluation 97
An efficient synthesis of 4-oxo-2,5-hexadienoates via Δ2-isoxazoline intermediates 88
Totale 6.677
Categoria #
all - tutte 27.965
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.965


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202122 0 0 0 0 0 0 0 0 0 0 0 22
2021/2022395 9 42 19 27 20 11 11 22 17 33 46 138
2022/2023488 41 44 6 78 82 74 16 50 63 2 18 14
2023/2024198 22 26 10 5 27 26 8 12 5 3 1 53
2024/2025902 15 24 66 54 98 74 28 49 115 116 129 134
2025/20262.578 288 91 220 380 397 188 229 108 259 289 94 35
Totale 6.677